Press Room

Award winning eye researchers showcase pioneering treatment for age-related macular degeneration at Denver annual conference - 5/3/2015
Award winning eye researchers showcase pioneering treatment for age-related macular degeneration at Denver annual conference

Former Broncos running back Terrell Davis to join combat-blinded veterans and top researchers at session to discuss brain injury and its effects - 4/28/2015
ARVO is combining presentations from some of the top researchers in TBI with perspectives from three blinded U.S. military veterans, who will share their stories of vision loss as a result of TBI suffered in combat situations. The vets’ presentation will be followed by a moderated Q&A/ discussion, in which attendees are encouraged to participate. Former NFL running back Terrell Davis will speak about the need for more research to support veterans, athletes and others whose lives have been devastated by TBI.

Knights Templar Eye Foundation funds 59 travel grants to ARVO 2015 - 4/17/2015
ARVO has awarded an additional 59 travel grants to help student/trainee members attend the 2015 Annual Meeting, thanks to a first-time grant to the ARVO Foundation for Eye Research from the Knights Templar Eye Foundation, Inc. (KTEF).

Carnival game mimics eye growth - 3/24/2015
The motion of coins in a “Penny Pusher” carnival game is similar to the movement of cells in the eye’s lens, as described in a new study published in Investigative Ophthalmology & Visual Science (IOVS). This new insight may help scientists understand how the eye maintains its precise shape — critical for clear vision — and how cataracts develop.

Restoring Vision to the Blind - 1/7/2015
Scientists have long known that species such as amphibians and fish can regenerate retinal cells — so why can’t mammals? This and related questions are the premise for the third report from the Albert and Mary Lasker Foundation and the International Retinal Research Foundation’s 10-year collaboration, recently published in the ARVO journal Translational Vision Science & Technology (TVST).

New findings show chronic high blood pressure increases risk of glaucoma - 12/22/2014
A new study published in Investigative Ophthalmology & Visual Science (IOVS) has found that chronic (long term) hypertension increases a person’s susceptibility to glaucoma. These results suggest that doctors should consider a patient’s blood pressure levels in managing the potentially blinding eye disorder.

New poll: Americans fear blindness more than loss of other senses, strongly support more funding for research - 9/18/2014
According to a new poll, Americans across racial and ethnic groups describe losing eyesight as potentially having the greatest impact on their day-to-day life — more so than other conditions, including loss of memory, hearing and speech.

ARVO members honored with world’s largest prize in eye research - 9/10/2014
Seven members of the Association for Research in Vision and Ophthalmology (ARVO) were named today as recipients of the 2014 António Champalimaud Vision Award, the highest distinction in ophthalmology and visual science, for their pioneering work to treat age-related macular degeneration (AMD) and diabetic retinopathy, the most important causes of blindness in high and middle income countries. The prize is worth €1 million (U.S. $1.3 million; greater than the Nobel Prize award).

Is glaucoma a brain disease? - 6/5/2014
Findings from a new study published in Translational Vision Science & Technology (TVST) show the brain, not the eye, controls the cellular process that leads to glaucoma. The results may help develop treatments for one of the world’s leading causes of irreversible blindness, as well as contribute to the development of future therapies for preserving brain function in other age-related disorders like Alzheimer’s.

Mieler begins term as ARVO president - 5/22/2014
William F. Mieler, MD, FARVO (University of Illinois at Chicago), is the new president of the Association for Research in Vision and Ophthalmology (ARVO). He succeeds Justine Smith, FRANZCO, PhD, FARVO (Flinders University), whose one-year term ended this month following the ARVO Annual Meeting.

Emerging trends and hot topics: Presented Thursday, May 8 at the ARVO Annual Meeting - 5/8/2014
In their own words, First Authors at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology explain their findings. Their abstracts were designated as some of the newest and most innovative research presented on Thursday, May 8.

New automated tool can screen for diabetic retinopathy - 5/8/2014
Scientists have developed a computer program to screen for diabetic retinopathy, a potentially blinding condition that may affect every person with diabetes. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week.

Emerging trends and hot topics: Presented Wednesday, May 7 at the ARVO Annual Meeting - 5/7/2014
In their own words, First Authors at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology explain their findings. Their abstracts were designated as some of the newest and most innovative research presented on Wednesday, May 7. 

Non-invasive technique can identify genetic carriers of eye disease - 5/7/2014
Scientists have developed a non-invasive technique to determine if individuals carry a gene for an inherited eye disease known as retinitis pigmentosa. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla. 

Elevating brain fluid pressure could prevent vision loss - 5/7/2014
Scientists have found that pressure from the fluid surrounding the brain plays a role in maintaining proper eye function, opening a new direction for treating glaucoma — the second leading cause of blindness worldwide. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla. 

Study shows remote evaluation as effective as a doctor’s visit for AMD patients - 5/7/2014
Researchers have found that patients received similar care for wet age-related macular degeneration (AMD) whether being evaluated by a doctor in-person or remotely. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla. 

Researchers find new drug treatment for eye muscle condition - 5/7/2014
In another example of serendipity advancing scientific research, investigators have discovered a new class of drugs to treat an eye condition called nystagmus. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla.

Emerging Trends and hot topics: Presented Tuesday, May 6 at the ARVO Annual Meeting - 5/6/2014
In their own words, First Authors at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology explain their findings. Their abstracts were designated as some of the newest and most innovative research presented on Tuesday, May 6.

Patients with AMD may not need monthly injections - 5/6/2014
Researchers have found that, contrary to previous clinical trial findings, monthly injections to counteract age-related macular degeneration (AMD) may not be necessary. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla.

Emerging Trends and hot topics: Presented Monday, May 5 at the ARVO Annual Meeting - 5/5/2014
In their own words, First Authors at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology explain their findings. Their abstracts were designated as some of the newest and most innovative research presented on Monday, May 5.

12Next
Advertisement
FASEB 2015